An interventional study of Mental Health Recovery Star (MHRS) in Severe Mental Disorder and Severe Mental Illness, sponsored by IRCCS Centro San Giovanni di Dio Fatebenefratelli. Recruiting at 3 sites in Italy. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-03.
Sponsored by IRCCS Centro San Giovanni di Dio Fatebenefratelli · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The project focuses on patients with severe mental disorders (SMD) residing in Italian mental health supported accommodation (SA). Although the goal of SA is to promote personal recovery - that is, living life to the fullest of one's potential - international literature on this topic is scarce, and traditional treatments in the Italian residential system show limitations in adopting such approaches.
The research hypothesis is that activating personal recovery pathways could improve the biopsychosocial outcomes of patients, caregivers, and professionals. To test this hypothesis, a non-pharmacological, non-randomized interventional trial will compare two groups: one group of individuals with SMD receiving recovery-oriented treatment, using the Mental Health Recovery Star, and another group of individuals with SMD receiving standard treatment.
The Mental Health Recovery Star is a ten-pointed star-shaped tool that represents various life dimensions. Patients, together with their key professional, are expected to negotiate a score for each domain on the five-stage 'Scale of Change,' capturing and monitoring the different phases of the recovery process.
Interventional Study Design Primary Purpose Treatment: A personal recovery-oriented intervention is being evaluated for treating people with severe mental disorders living in mental health supported accommodations Study Phase
The project will last three years and will follow these phases:
Patients will be matched based on sex, age range (e.g., 18-25, 26-40, 41-60, 61-70), and diagnostic group according to the DSM-5-TR (schizophrenia spectrum disorders, mood disorders, personality disorders, other). Regardless of the number of patients recruited for each diagnostic category, all patients will be included in the sample, as literature indicates that residing in a specific type of residential facility makes them comparable in terms of functioning and care needs.
Assessments will be conducted at baseline (BL) and at two follow-up time points: six months and nine months (FU).
Number of Arms Two arms. Masking No masking Allocation Nonrandomized: Participants are expressly assigned to intervention groups through a non-random method, such as those whose assigned professionals have completed or not a specific training on personal recovery.
Enrollment 72 participants: 36 for the experimental group and 36 for the control group.
1,746 studies on the registry are indexed under Mental Disorders; 350 are open to participants now.
This study's planned enrollment of 72 is below the median of 100 across 1,305 interventional studies indexed under Mental Disorders.
Browse Mental Disorders studies →IRCCS Centro San Giovanni di Dio Fatebenefratelli is the lead sponsor of 36 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study population will include:
Patients with a mental disorder inclusion criteria:
Informal caregivers of patients inclusion criteria:
Mental health professionals inclusion criteria:
A group of residents will receive a personal recovery-oriented treatment (N=36) whose key professionals have participated in specific training on personal recovery.
Behavioral: Mental Health Recovery Star (MHRS)
A group of residents will receive standard treatment (N=36). Standard residential treatment for individuals with mental disorders includes medical, psychological, and social interventions aimed at improving symptoms, quality of life, and functioning. The approach is personalized based on the individual's diagnosis, symptoms, and community resources. Most SAs offer personalized care plans, designated key professionals, regular individual and group activities, medication management support, and healthy lifestyle promotion. However, few facilities provide continuous psychological, vocational, and social support, adequately addressing patients' real needs.
The personal recovery-oriented treatment is the Mental Health Recovery Star (MHRS), a recovery-oriented tool developed in England to support and monitor personal recovery. It features a 10-point star representing life dimensions grouped into four areas: health, functioning, self-image, and social networks. Residents assess their progress on each point using a "Scale of Change " with five recovery stages, from feeling stuck to self-reliance. After assessment, residents and professionals set recovery goals (up to three at a time) and create a shared care plan. The MHRS shows good psychometric properties, with strong validity, consistency, and ease of use, despite some inter-rater reliability issues. It is best suited for shared rehabilitation plans rather than clinical monitoring. Peer review meetings will be provided. The personal recovery-oriented treatment will last six months and will be considered complete upon follow-up evaluation.
Psychosocial functioning
Personal and Social Functioning Scale (FPS): assesses four key domains (socially useful activities, personal and social relationships, self-care and hygiene, and disruptive/aggressive behaviors) with scores ranging from 0 to 100, where higher scores indicate better functioning.
Time frame: at baseline and at 6 and 9 months follow-up
Rehabilitation goals
Valutazione delle Attività e Definizione degli Obiettivi (VADO) \[Assessment of Activities and Goal Setting\]: Includes the Rehabilitation Areas Module (28 items, rated on a 4-point Likert scale), where higher scores indicate higher professional interventions.
Time frame: at baseline and at 6-9 months follow-up
Stress-related parameters
Biological changes related to stress will be assessed through the collection of saliva samples (for three consecutive days) and blood samples to investigate High-sensitivity CRP, and pro-inflammatory cytokines IL-6, TNF-alpha, IL-1, IL-4, IL-10, hormone panel (Testosterone, E2, FSH, LH, SHBG, P4, PRL), concentration and size of extracellular vesicles (EVs).
Time frame: at baseline and at 6-9 months follow-up
Real-time experiences
A focus group with the patients will be conducted to collaboratively define the questions for the Experience Sampling Method (ESM) questionnaire about psychopathology, involvement in productive activities, diet, use of social media, and interpersonal relationships. Data will be explored ecologically, in real-time, and longitudinally through a custom-designed app for the project, which will send daily notifications with a brief questionnaire to be developed and administered to patients via mobile app.
Time frame: at baseline and at 6-9 months follow-up for 1 week, and partly for 6 months along the experimental or control treatment
Physical Activity-Related Parameters
Changes in physical activity will be assessed using an accelerometer (worn for one week)
Time frame: for 1 week at baseline and at 6-9 months follow-up
Working alliance
The working alliance between patients and mental health professionals will be assessed using the Working Alliance Scale (WAI 41) at BL and FU.
Time frame: at baseline and at 6-9 months follow-up
Psychopathology
Brief Psychiatric Rating Scale (BPRS): Evaluates psychopathology severity through 24 items rated on a 7-point Likert scale, covering five symptom categories (depression/anxiety, excitement, positive symptoms, negative symptoms, and cognitive symptoms). Higher scores indicate greater symptom severity.
Time frame: at baseline and at 6-9 months follow-up
Psychipathology and fucntioning in residential facility
Health of the Nation Outcome Scale - Residential Facility (HoNOS-RF): Measures personal and interpersonal functioning, environment, medical aspects, cognitive problems, and psychiatric symptoms. The 33 items are rated on a 0-4 Likert scale (higher scores indicate greater severity).
Time frame: at baseline and at 6-9 months follow-up
Needs for care
Camberwell Assessment of Need (CAN): Evaluates needs for care through a 22-item interview for both staff (CAN-S) and patients (CAN-P), rated on a 3-point scale (0 = no problem, 1 = problem managed with intervention, 2 = unmet need).
Time frame: at baseline and at 6-9 months follow-up
Functional autonomy in residential facility
Monitoring of Pathway of Rehabilitation (MPR): Assesses functional autonomy across 10 skill areas (self-care, living space maintenance, nutrition, orientation/movement, other autonomies, social skills, socio-recreational abilities, occupational skills, health management). Scores range from 0 to 12, with higher scores indicating greater functional autonomy.
Time frame: at baseline and at 6-9 months follow-up
Personal recovery -short
Hope, Agency and Opportunity (HAO): A 4-item questionnaire monitoring personal recovery, with higher scores indicating more favorable recovery outcomes.
Time frame: at baseline and at 6-9 months follow-up
Personal recovery
Recovery Assessment Scale - Domains and Stages (RAS-DS): Measures personal recovery through four key areas (hope and optimism, sense of belonging and social support, life goals and future orientation, illness management and coping skills) and five stages reflecting progress in the recovery process.
Time frame: at baseline and at 6-9 months follow-up
Quality of life and exploitation
Manchester Short Assessment of Quality of Life (MANSA): explores the patient's perception about its living situation and health. Higher scores reflect better quality of life.
Time frame: at baseline and at 6-9 months follow-up
Perceived functioning/disability
WHO Disability Assessment Schedule (WHODAS 2.0): Evaluates perceived functioning through a 12-item scale rated on a 5-point Likert scale, with higher scores indicating greater disability.
Time frame: at baseline and at 6-9 months follow-up
Stigma
Discrimination and Stigma Scale - Ultra Short (DISC-US): Measures perceived stigma through an 11-item questionnaire rated on a 4-point Likert scale, where higher scores indicate greater perceived discrimination.
Time frame: at baseline and at 6-9 months follow-up
Perceived loneliness
UCLA Loneliness Scale: A 20-item scale measuring perceived loneliness, rated on a 4-point Likert scale, with higher scores indicating greater loneliness.
Time frame: at baseline and at 6-9 months follow-up
Therapeutic alliance
Working Alliance Inventory - Short Form (WAI): Assesses therapeutic alliance using 12 items rated on a 7-point Likert scale, where higher scores indicate a stronger alliance.
Time frame: at baseline and at 6-9 months follow-up
Service satisfaction
Verona Service Satisfaction Scale - Residential Facilities (VSSS-RF): Measures service satisfaction from the patient's and informal caregiver perspective using a 24-item questionnaire rated on a 5-point Likert scale, covering overall satisfaction, staff competence, intervention effectiveness, information, access, and family involvement.
Time frame: at baseline and at 6-9 months follow-up
Burnout Assessment Tool (BAT)
Burnout Assessment Tool (BAT): The BAT is a psychometrically valid tool, recently developed and not subject to a paid license, making it more accessible for non-profit multicenter studies.
Time frame: at baseline and at 6- 9 months follow-up
Perceived stress
Perceived Stress Scale (PSS): A 10-item self-report questionnaire measuring perceived stress over the last 30 days.
Time frame: at baseline and at 6-9 months follow-up
Job satisfaction
Ad-hoc questionnaire: Evaluates job satisfaction. 11 items. higher scores indicate greater job satisfaction.
Time frame: at baseline and at 6-9 months follow-up
Distress
Patient Health Questionnaire-4 (PHQ-4): A 4-item screening tool for anxiety and depression symptoms, with higher scores indicating greater distress and functional impairment.
Time frame: at baseline and at 6-9months follow-up
Experiences of caregiving
Positive Aspects of Caregiving (PAC): Measures the positive experiences and benefits of caregiving, including feelings of usefulness, appreciation, and meaning in the caregiving relationship.
Time frame: at baseline and at 6-9 months follow-up
Circadian rythm- related parameters
Changes in circadian rythm will be assessed using an accelerometer
Time frame: one week at baseline and at 6-9 months follow-up
Specific Levels of Functioning Scale (SLOF)
Specific Levels of Functioning Scale (SLOF): Assesses psychosocial functioning. It consists of 43 items rated on a 5-point Likert scale, with total scores ranging from 43 to 215, where higher scores indicate better psychosocial functioning.
Time frame: at baseline and at 6 and 9 months follow-up
Triadic Interaction, aAliance, and Dynamic evaluation (TRIADE)
Triadic Interaction, aAliance, and Dynamic evaluation (TRIADE): tool for assessing the alliance and reciprocal influence within the triadic care system (25 items, 1-7 likert scale; higher scores indicate stronger influence; validation ongoing)
Time frame: at baseline and at 6 and 9 months follow-up
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Assesses cognitive functions through 12 subtests grouped into 5 index scores. Scores below the mean indicate cognitive difficulties or possible impairment.
Time frame: at baseline and at 6-9 months follow-up
Resilience Scale - 14 item (RS-14):
Resilience Scale - 14 item (RS-14): Measures personal resilience across 14 items; higher scores indicate greater resilience.
Time frame: at baseline and at 6 and 9 months follow-up
Quality Indicator for Rehabilitative Care - Short Assessment (QuIRC-SA)
Time frame: once in 6 months from the baseline
WHO Quality of Life-Brief scale (WHOQOL-Brief)
WHO Quality of Life-Brief scale (WHOQOL-Brief): Assesses quality of life (26 items, 4 domains, 5-point Likert scale, range 0-100; higher scores indicate better quality of life).
Time frame: at baseline and at 6 and 9 months follow-up
Zarit Burden Interview (ZBI)
Zarit Burden Interview (ZBI): Measures caregiver burden (29 items, 6 domains, 0-4 Likert scale; higher scores indicate greater burden).
Time frame: at baseline and at 6 and 9 months follow-up
Plan to share: Yes — To promote open, transparent, and collaborative science, the raw data from all studies conducted at the IRCCS Fatebenefratelli will be published in publicly accessible repositories, as required by the scientific community and funding bodies, including the Ministry of Health and the European Commission. The raw clinical and biological data related to participants in this research, a non-randomized multicenter non-pharmacological clinical trial, will be published in a form that ensures the protection of participants' privacy in accordance with current regulations. Repositories will be selected that allow access to the information only after authentication of the access request and validation by the study responsible (or a designated representative) of the reasons for the request. The public repository will also be chosen based on the cybersecurity and data protection guarantees it offers.
Supporting information: Study protocol
Time frame: From December 2028 to Dcember 2029
Access criteria: De-identified clinical and biological data from this non-randomized multicenter trial will be available in secure public repositories to support open science. Eligibility: Access is granted for research aligned with study objectives, including secondary and meta-analyses. Requests must detail statistical methods, subject to independent review. Privacy \& Security: Data will comply with protection regulations, stored only in repositories with strong cybersecurity measures. Access Process: Researchers must submit a formal request and sign a Data Sharing Agreement (DSA) before access is granted. Authentication via the repository's system is required. Review \& Approval: Requests will be evaluated by the study lead (or representative) based on scientific merit, ethical compliance, and feasibility.
No publications or documents are linked to this record.
Started Jan 2026 (actual). Primary completion is estimated for Dec 2027, 23 months after the start.
Of 668 non-industry interventional studies with no phase under Mental Disorders, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 45. This study's planned 23 months is below that.
Counting every sponsor, half of 682 studies reached it within 29 months; a quarter within 13 and three quarters within 45.
Mental Disorders covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
IRCCS Centro San Giovanni di Dio Fatebenefratelli